Pamela A Frischmeyer-Guerrerio

Dr. Pamela A Frischmeyer-Guerrerio


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
MGMark Gorelik
Mark Gorelik
SNSatya D. Narisety
Satya D. Narisety
AGAnthony L. Guerrerio
Anthony L. Guerrerio
KCKristin L. Chichester
Kristin L. Chichester
CKCorinne A. Keet
Corinne A. Keet
PFPamela A Frischmeyer-Guerrerio
Pamela A Frischmeyer-Guerrerio

3 July 2024 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
RSRachel Sparks
Rachel Sparks
NRNicholas Rachmaninoff
Nicholas Rachmaninoff
WLWilliam W. Lau
William W. Lau
DHDylan C. Hirsch
Dylan C. Hirsch
NBNeha Bansal
Neha Bansal
JTJohn S. Tsang
John S. Tsang

22 January 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
DMDaniel R. Monaco
Daniel R. Monaco
BSBrandon M. Sie
Brandon M. Sie
TNThomas R. Nirschl
Thomas R. Nirschl
AKAudrey C. Knight
Audrey C. Knight
HSHugh A. Sampson
Hugh A. Sampson
HLH. Benjamin Larman
H. Benjamin Larman
Allergic reactions occur when IgE molecules become crosslinked by antigens such as food proteins. Here we create the ‘AllerScan’ programmable phage display system to characterize the binding specificities of anti-allergen IgG and IgE antibodies in serum against thousands of allergenic proteins from hundreds of organisms at peptide resolution. Using AllerScan, we identify robust anti-wheat IgE reactivities in wheat allergic individuals but not in wheat-sensitized individuals. Meanwhile, a key wheat epitope in alpha purothionin elicits dominant IgE responses among allergic patients, and frequent IgG responses among sensitized and non-allergic patients. A double-blind, placebo-controlled trial shows that alpha purothionin reactivity, among others, is strongly modulated by oral immunotherapy in tolerized individuals. AllerScan may thus serve as a high-throughput platform for unbiased analysis of anti-allergen antibody specificities.

1 May 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
KWKatherine A. Weissler
Katherine A. Weissler
MRMarjohn Rasooly
Marjohn Rasooly
TDTom DiMaggio
Tom DiMaggio
HBHyejeong Bolan
Hyejeong Bolan
DCDaly Cantave
Daly Cantave
PFPamela A Frischmeyer-Guerrerio
Pamela A Frischmeyer-Guerrerio

13 January 2023 in Science Immunology
Verified
Journal Article
Closed access
KLKaren Laky
Karen Laky
JKJessica L. Kinard
Jessica L. Kinard
JLJenny Min Li
Jenny Min Li
IMIan N. Moore
Ian N. Moore
JLJustin Lack
Justin Lack
PFPamela A Frischmeyer-Guerrerio
Pamela A Frischmeyer-Guerrerio
Allergic diseases are a global health challenge. Individuals harboring loss-of-function variants in transforming growth factor–β receptor (TGFβR) genes have an increased prevalence of allergic disorders, including eosinophilic esophagitis. Allergic diseases typically localize to mucosal barriers, implicating epithelial dysfunction as a cardinal feature of allergic disease. Here, we describe an essential role for TGFβ in the control of tissue-specific immune homeostasis that provides mechanistic insight into these clinical associations. Mice expressing a TGFβR1 loss-of-function variant identified in atopic patients spontaneously develop disease that clinically, immunologically, histologically, and transcriptionally recapitulates eosinophilic esophagitis. In vivo and in vitro, TGFβR1 variant–expressing epithelial cells are hyperproliferative, fail to differentiate properly, and overexpress innate proinflammatory mediators, which persist in the absence of lymphocytes or external allergens. Together, our results support the concept that TGFβ plays a fundamental, nonredundant, epithelial cell–intrinsic role in controlling tissue-specific allergic inflammation that is independent of its role in adaptive immunity.

26 January 2018 in Current Allergy and Asthma Reports
Verified
Journal Article
Closed access
PDF file
CCCristina A. Carter
Cristina A. Carter
PFPamela A Frischmeyer-Guerrerio
Pamela A Frischmeyer-Guerrerio